Recipient
Galenvs Sciences Inc.Department
National Research Council CanadaAmount
$63.0K
Province
QCType
Contribution
Agreement Number
172-2024-2025-Q3-1022902
Purpose
The firm is advancing the development of rapid diagnostic workflows for detecting Haplosporidium nelsoni in oysters, leveraging its expertise in sample preparation using magnetic nanoparticles and specialized buffer formulations. The project focuses on the efficient extraction of genomic material, the design of sensitive PCR and isothermal detection systems, and the production of high-purity oligonucleotide probes and primers. With ISO 9001-certified manufacturing capabilities, the firm is well-positioned to commercialize these diagnostic tools, enhancing pathogen detection and supporting the oyster industry.
Galenvs Sciences Inc. × National Research Council Canada
9 grants totalling $2.2M
Industrial Research Assistance Program – Contributions to Firms
1,000 grants totalling $112.4M
Related Grants
| Recipient | Amount | Program |
|---|---|---|
| Providence Therapeutics Holdings Inc. | $10.0M | Industrial Research Assistance Program –... |
| Entos Pharmaceuticals Inc. | $10.0M | Industrial Research Assistance Program –... |
| Entos Pharmaceuticals Inc. | $10.0M | Industrial Research Assistance Program –... |
| Laurent Pharmaceuticals Inc. | $10.0M | Industrial Research Assistance Program –... |
| Laurent Pharmaceuticals Inc. | $10.0M | Industrial Research Assistance Program –... |